Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management
Cholera: Individualised risk assessment for travellers
+Practice
In print
Travel medicine
Cholera: Individualised risk assessment for travellers
Wednesday 31 July 2024, 12:15 AM
![Toilet_Rolls](/sites/default/files/styles/cropped_image_16_7_/public/2024-07/Toilet_Rolls_CR_erik-mclean-GNHkPsONmac-unsplash-%281%29.jpg?itok=MxDSFIl3)
Cholera is considered a low-incidence disease in travellers, but the true impact is difficult to assess [Image: Erik Mclean on Unsplash]
This article summarises three papers about cholera, including the global situation, a new vaccine on its way, and guidelines on who should get vaccinated
This Practice article has been endorsed by the RNZCGP and has been approved for up to 0.25 credits for continuing professional development purposes (1, Educate small, BACK panel - grey
References
1. WHO. Multi-country outbreak of cholera. External Situation Report n. 15. 19 June 2024.
2. Levine MM, Chen WH, Kaper JB, et al. PaxVax CVD 103-HgR single-dose live oral cholera vaccine. Expert Rev Vaccines 2017;16(3):197–213.
3. López-Vélez R, Presotto D. Cholera in travellers: improving vaccination guidance in Europe. J Travel Med 2021;28(1):taaa209.